Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways
Xue‐hai Liang, Hong Sun, Joshua G Nichols, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 19, pp. 10225-10245
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Phosphorothioate modified oligonucleotide–protein interactions
Stanley T. Crooke, Timothy A. Vickers, Xue‐hai Liang
Nucleic Acids Research (2020) Vol. 48, Iss. 10, pp. 5235-5253
Open Access | Times Cited: 247
Antisense technology: A review
Stanley T. Crooke, Xue‐hai Liang, Brenda F. Baker, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100416-100416
Open Access | Times Cited: 237
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents
Stanley T. Crooke, Punit P. Seth, Timothy A. Vickers, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 35, pp. 14754-14771
Closed Access | Times Cited: 103
Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines
Emily Linnane, Paul R. J. Davey, Pei Zhang, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 9, pp. 4375-4392
Open Access | Times Cited: 85
Drug Discovery Perspectives of Antisense Oligonucleotides
Yeonjoon Kim
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 3, pp. 241-252
Open Access | Times Cited: 27
Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs
Virginie Baylot, Thi Khanh Le, David Taïeb, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells
Shiyu Wang, Nickolas Allen, Thazha P. Prakash, et al.
Nucleic Acid Therapeutics (2019) Vol. 29, Iss. 5, pp. 245-255
Closed Access | Times Cited: 57
A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics
Kirsten Deprey, Nefeli Batistatou, Joshua A. Kritzer
Nucleic Acids Research (2020) Vol. 48, Iss. 14, pp. 7623-7639
Open Access | Times Cited: 55
High-resolution visualization and quantification of nucleic acid–based therapeutics in cells and tissues using Nanoscale secondary ion mass spectrometry (NanoSIMS)
Cuiwen He, Michael T. Migawa, Kai Chen, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. 1, pp. 1-14
Open Access | Times Cited: 53
mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway
Xue‐hai Liang, Joshua G Nichols, Chih‐Wei Hsu, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 13, pp. 6900-6916
Open Access | Times Cited: 46
Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide
Keisuke Tanaka, Takumi Okuda, Yuuya Kasahara, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 440-449
Open Access | Times Cited: 42
Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
Thijs Van de Vyver, Stefaan C. De Smedt, Koen Raemdonck
Advanced Drug Delivery Reviews (2021) Vol. 181, pp. 114041-114041
Open Access | Times Cited: 38
Insights into innate immune activation via PS-ASO–protein–TLR9 interactions
Adam J. Pollak, Luyi Zhao, Timothy A. Vickers, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 14, pp. 8107-8126
Open Access | Times Cited: 23
Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes
Xue‐hai Liang, Hong Sun, Chih‐Wei Hsu, et al.
Nucleic Acids Research (2019) Vol. 48, Iss. 3, pp. 1372-1391
Open Access | Times Cited: 36
The Coming Age of Antisense Oligos for the Treatment of Hepatic Ischemia/Reperfusion (IRI) and Other Liver Disorders: Role of Oxidative Stress and Potential Antioxidant Effect
Siyuan Yao, Aanchal Kasargod, Richard Chiu, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 678-678
Open Access | Times Cited: 4
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy
Socheata Ly, Dimas Echeverria, Jacquelyn Sousa, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 991-1005
Open Access | Times Cited: 31
Retinal proteomics of experimental glaucoma model reveal intraocular pressure‐induced mediators of neurodegenerative changes
Mehdi Mirzaei, Vivek Gupta, Nitin Chitranshi, et al.
Journal of Cellular Biochemistry (2020) Vol. 121, Iss. 12, pp. 4931-4944
Closed Access | Times Cited: 26
Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery
Rudolph L. Juliano
Biomedicines (2021) Vol. 9, Iss. 5, pp. 512-512
Open Access | Times Cited: 22
Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis
Ekta Pandey, Edward N. Harris
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 430-443
Open Access | Times Cited: 9
Recent advances in methods for quantifying the cell penetration of macromolecules
Nefeli Batistatou, Joshua A. Kritzer
Current Opinion in Chemical Biology (2024) Vol. 81, pp. 102501-102501
Closed Access | Times Cited: 3
New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape
Maja van Hees, Sofie Slott, Anders Højgaard Hansen, et al.
Molecular Therapy (2021) Vol. 30, Iss. 1, pp. 32-46
Open Access | Times Cited: 19
The bench to bedside journey of tricyclo-DNA antisense oligonucleotides for the treatment of Duchenne muscular dystrophy
Mathilde Blitek, Xaysongkhame Phongsavanh, Aurélie Goyenvalle
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3017-3025
Closed Access | Times Cited: 2
High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity
Jiyoung Oh, Chanho Park, Sahee Kim, et al.
Metabolism (2023) Vol. 145, pp. 155629-155629
Closed Access | Times Cited: 6
A novel and translational role for autophagy in antisense oligonucleotide trafficking and activity
Joseph Ochaba, Andrew F. Powers, Kaitlyn A Tremble, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 21, pp. 11284-11303
Open Access | Times Cited: 16
Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is Cytoprotective
Xue‐hai Liang, Cheryl Li De Hoyos, Wen Shen, et al.
Nucleic Acid Therapeutics (2021) Vol. 31, Iss. 2, pp. 126-144
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top